查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1999309

獸醫照護現場診斷市場：按動物種類、檢測類型、技術、檢體類型、應用和最終用戶分類－2026-2032年全球市場預測

Veterinary Point Of Care Diagnostics Market by Animal Type, Test Type, Technology, Sample Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，獸醫即時診斷市場價值將達到 21.9 億美元，到 2026 年將成長至 24.7 億美元，到 2032 年將達到 51.3 億美元，複合年成長率為 12.87%。

主要市場統計數據
基準年 2025 21.9億美元
預計年份：2026年 24.7億美元
預測年份 2032 51.3億美元
複合年成長率 (%) 12.87%

簡要介紹床邊診斷和燒傷場診斷如何改變當今獸醫學的提供和臨床決策。

獸醫領域的即時診斷正迅速從輔助工具轉變為動物醫療保健服務的核心要素。獸醫和畜牧管理者越來越需要在床邊和畜舍內獲得快速可靠的檢測結果，以便即時做出臨床決策、提高處理能力並減少因依賴中心檢查室而造成的物流障礙。攜帶式檢測化學技術、小型化分析儀和整合數位輸出的進步縮短了檢測結果的返回時間，使得在提供護理的當下即可獲得有意義的診斷。

對重新定義獸醫即時診斷和行業經營模式的關鍵技術、臨床和商業性變革進行分析。

在獸醫即時診斷領域，改變正在發生，重塑價值鏈、臨床工作流程和投資重點。其中一個顯著的變化是從一次性側向流動檢測裝置轉向更先進的、配備讀卡器且無需導聯的檢測裝置，從而實現定量輸出、互聯互通和結果標準化。這項轉變將有助於與臨床管理系統和遠距分診服務整合，使臨床醫生能夠自信地做出數據驅動的決策，並將診斷範圍擴展到遠端和行動臨床環境。

2025 年關稅調整對獸醫診斷設備和耗材的供應鏈、定價策略和採購選擇的影響。

2025年實施的費用調整的累積影響對整個獸醫診斷生態系統的籌資策略、定價機制和供應鏈韌性產生了顯著影響。費用波動增加了進口分析儀器、核心模組和關鍵試劑的總進口成本，這些產品通常在高度專業化的海外工廠生產。對於利潤空間較小的終端用戶，例如行動診所和小規模診斷檢查室，這些增加的成本迫使他們調整服務價格並延長設備更新週期。

將動物物種、診斷方法、最終用戶畫像和檢體處理途徑與可操作的產品和管道策略聯繫起來的全面細分洞察。

從臨床、技術和商業性等多個觀點分析市場，可以揭示關鍵的市場區隔洞察。依動物種類分類，需求模式可分為伴侶動物和牲畜。在伴侶動物領域，由於飼主期望和臨床症狀的差異，貓和狗在診斷應用方面有明顯差異。同時，在涵蓋牛、馬、家禽和豬的牲畜領域，加工能力、生物安全和批量檢測流程往往是優先考慮的因素。這些不同的需求會影響檢測套組的組成、分析儀器的處理能力和服務模式。

區域觀點著重介紹全球主要地區的獨特臨床需求、監管細微差別和商業性路徑。

區域趨勢影響市場接受度曲線、監管路徑和商業性優先事項，供應商和投資者在規劃市場進入和擴張時必須考慮這些因素。在美洲，市場需求集中在先進的伴侶動物醫療和整合臨床工作流程上，這得益於強大的私人獸醫網路以及飼主對高階診斷的投資意願。該地區的市場參與企業正著重強調設備性能、數位化整合和配套耗材，以此作為差異化優勢，而基於遠端醫療的診斷服務也呈現日益強勁的發展勢頭。

對成熟企業、專業獸醫公司和創新Start-Ups如何競爭與合作，從而在設備、耗材和服務方面創造價值進行策略評估。

獸醫照護現場診斷市場由眾多成熟的診斷服務提供者、專業的獸醫公司和靈活的Start-Ups組成，它們各自探索著不同的規模化發展路徑。現有儀器製造商利用其成熟的分銷網路和服務能力，向上提升銷售整合的儀器和耗材解決方案；而專業的獸醫公司則優先考慮臨床有效性和與獸醫工作流程相契合的產品設計。Start-Ups通常專注於高價值的單一應用、新型檢測方法或能夠簡化結果解讀和報告的數位化功能。

為供應商和投資者提供具體的策略建議，以加強獸醫診斷領域的產品系列、供應鏈、服務模式和監管合規性。

產業領導企業可以透過實施一系列重點策略措施來加速市場滲透並確保永續的競爭優勢。首先，應優先考慮模組化產品架構。能夠處理多種檢測類型和檢體基質的平台可以降低單位風險並提高生命週期效益。在保留用於定量和網路化工作流程的基於主控單元的產品線的同時，投資於低成本、高容量的無主控單元產品，可以擴大市場覆蓋範圍並提高定價柔軟性。

對用於建立實用見解的主要和次要調查方法、專家檢驗流程和資料三角測量技術進行透明的概述。

本分析的調查方法結合了初步的質性研究和嚴謹的二次檢驗，以確保研究結果具有臨床相關性和實踐基礎。初步研究包括對執業獸醫、檢查室主管、畜牧主管和產品開發經理進行結構化訪談，重點關注應用案例、採購決策標準以及對售後支援的期望。這些訪談揭示了產品接受度、工作流程整合以及現有診斷產品所面臨的挑戰等方面的真實情況。

一項決定性的整合，突顯了技術、服務交付和營運韌性之間的相互作用，這決定了獸醫診斷領域的長期成功。

總之，獸醫照護現場診斷技術已進入成熟階段，技術能力、服務設計和商業性彈性將決定其成敗。攜帶式分子診斷工具、改進的免疫檢測和數位化診斷平台的融合，為診斷技術從一次性應用轉向伴侶動物診所和畜牧場的常規應用鋪平了道路。然而，要實現其持續普及，還需要考慮終端用戶的經濟負擔、建立穩健的供應鏈，以及在不同動物物種和不同情況下證明其可衡量的臨床效用。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 獸醫照護現場診斷市場：依動物類型分類

  • 伴侶動物
    • 貓
    • 狗
  • 家畜
    • 牛
    • 馬
    • 家禽
    • 豬

第9章 獸醫照護現場診斷市場：檢測類型

  • 生物化學
    • 化學分析儀
    • 電解質分析儀
  • 血液學
    • 血球計數器
    • 血紅素分析儀
  • 免疫檢測
    • ELISA
    • 橫向流動化驗
  • 分子診斷

第10章 獸醫照護現場診斷市場：依技術分類

  • 領導風格
  • 無領導

第11章檢體類型照護現場診斷市場

  • 血
  • 屎
  • 牛奶
  • 唾液
  • 尿

第12章 獸醫照護現場診斷市場：依應用領域分類

  • 心臟監測
  • 重症監護
  • 感染疾病
  • 代謝篩檢

第13章 獸醫照護現場診斷市場：依最終用戶分類

  • 診斷檢查室
  • 醫院和診所
  • 研究機構

第14章 獸醫照護現場診斷市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 獸醫照護現場診斷市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 獸醫照護現場診斷市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章：美國獸醫照護現場診斷市場

第18章：中國獸醫照護現場診斷市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Agrolabo Spa
  • B. Braun SE
  • Biogal Galed Labs
  • BioMerieux SA
  • BioNote, Inc.
  • Chembio Diagnostic Systems, Inc. by Biosynex
  • Dispomed Ltd.
  • Esaote SpA
  • Fassisi GmbH
  • FUJIFILM Holdings Corporation
  • Heska Corporation by Mars Inc.
  • IDEXX Laboratories, Inc.
  • Medtronic PLC
  • Mindray Medical International Limited
  • Neogen Corporation
  • Nova Biomedical Corporation
  • Precision Biosensor Inc.
  • Randox Laboratories Ltd.
  • Shenzhen Mindray Animal Medical Technology Co., Ltd.
  • Thermo Fisher Scientific Inc.
  • Vimian Group AB
  • Virbac Corporation
  • Woodley Equipment Company Inc.
  • Zoetis Inc.
Product Code: MRR-3A2E844FD625

The Veterinary Point Of Care Diagnostics Market was valued at USD 2.19 billion in 2025 and is projected to grow to USD 2.47 billion in 2026, with a CAGR of 12.87%, reaching USD 5.13 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.19 billion
Estimated Year [2026] USD 2.47 billion
Forecast Year [2032] USD 5.13 billion
CAGR (%) 12.87%

A succinct introduction framing how bedside and barnside diagnostics are reshaping veterinary care delivery and clinical decision making today

Veterinary point-of-care diagnostics are rapidly transitioning from niche adjuncts to core elements of animal healthcare delivery. Vets and livestock managers increasingly demand fast, reliable test results at the bedside or barn to enable immediate clinical decisions, improve throughput, and reduce the logistical friction associated with centralized laboratories. Advances in portable assay chemistry, miniaturized analyzers, and integrated digital output have compressed turnaround times and allowed for meaningful diagnostics at the time and place of care.

This evolution is driven by several converging forces. Rising companion animal ownership and heightened willingness to invest in pet health are reshaping clinical expectations, while intensifying pressure to optimize herd health and biosecurity in livestock sectors is pushing farm managers to adopt more proactive diagnostic workflows. Concurrently, technological maturation across immunoassays, molecular platforms, and sensor technologies has enabled greater analytical performance in compact formats. Regulatory clarity in some jurisdictions and expanding training programs for veterinary professionals are reducing barriers to adoption.

Taken together, these dynamics are enabling practitioners to close the gap between clinical suspicion and verification, supporting earlier interventions, more targeted therapeutics, and measurable improvements in animal welfare and operational efficiency. The remainder of this executive summary examines the transformational shifts, segmentation nuances, regional differences, corporate responses, and strategic recommendations that leaders must weigh when engaging this dynamic market.

An analysis of the pivotal technological, clinical, and commercial shifts that are redefining point-of-care veterinary diagnostics and industry business models

The landscape of veterinary point-of-care diagnostics is undergoing transformative shifts that reconfigure value chains, clinical workflows, and investment priorities. One prominent change is the migration from single-use lateral flow devices toward more sophisticated reader-based and reader-less formats that enable quantitative outputs, connectivity, and result standardization. This shift supports integration with practice management systems and teletriage services, allowing clinicians to make data-driven decisions with confidence and to extend diagnostic reach into remote and ambulatory settings.

Simultaneously, molecular diagnostics are moving out of centralized labs and into near-patient environments, driven by simplified sample preparation, isothermal amplification methods, and cartridgeized consumables. The democratization of higher-sensitivity tests alters diagnostic pathways for infectious disease management in both companion animals and livestock, enabling faster containment and targeted therapeutics. Artificial intelligence and cloud analytics are adding a layer of interpretation to raw outputs, helping clinicians prioritize cases and identify epidemiological signals earlier.

As business models evolve, manufacturers and distributors are adopting service-centric approaches that bundle instruments with reagents, calibration services, and digital subscriptions to lock in lifetime value and improve predictability. These shifts are forcing legacy vendors to accelerate innovation cycles and newer entrants to demonstrate clinical validation, regulatory compliance, and cost-effective service operations. The aggregate result is a more connected, agile, and clinically impactful diagnostic ecosystem for animal health.

How the 2025 tariff adjustments reshaped supply chains, pricing strategies, and procurement choices across veterinary diagnostic equipment and consumables

The cumulative impact of tariff changes implemented in 2025 has materially influenced procurement strategies, pricing mechanisms, and supply chain resilience across the veterinary diagnostics ecosystem. Tariff dynamics have increased the landed cost of imported analyzers, reader modules, and critical reagent inputs that are often manufactured in highly specialized overseas facilities. For end users operating on tight margins, such as ambulatory clinics and small diagnostic laboratories, incremental cost increases create pressure to reprice services or lengthen replacement cycles for capital equipment.

Manufacturers and distributors responded by accelerating localization and dual-sourcing strategies. Some moved production of high-volume consumables to regional contract manufacturers, while others prioritized inventory hedging and multi-tier distribution to buffer short-term volatility. These maneuvers improved responsiveness but increased working capital requirements and added complexity to inventory management. In parallel, tariff-related cost pressures incentivized product redesigns that reduced reliance on tariffed components and optimized supply chains for modular assembly closer to major end-user markets.

From a market access viewpoint, tariff changes encouraged a sharper segmentation of value propositions. Vendors emphasized total cost of ownership, service reliability, and integrated consumables bundles to justify pricing in tariff-inflated environments. The net effect is a more defensive and strategically diversified industry posture, with opportunities for regional manufacturers to capture share where local production can undercut tariff-affected imports and for agile suppliers to offer differentiated service and subscription models that dampen immediate price sensitivity.

A comprehensive set of segmentation insights tying animal species, diagnostic modalities, end-user profiles, and sample pathways to actionable product and channel strategies

Key segmentation insights emerge when the market is examined through multiple lenses that reflect clinical, technological, and commercial realities. By animal type, demand patterns bifurcate between companion animals and livestock; within the companion segment, cats and dogs exhibit distinct diagnostic use cases driven by differences in caregiver expectations and clinical presentation, while livestock demands-spanning cattle, horses, poultry, and swine-tend to prioritize throughput, biosecurity, and batch testing workflows. These divergent needs affect kit formulation, analyzer throughput, and service models.

When tests are disaggregated by type, biochemistry solutions, which include chemistry analyzers and electrolyte analyzers, remain foundational for routine metabolic screening and critical care. Hematology instruments such as cell counters and hemoglobin analyzers are core to anemia workup and infection monitoring. Immunoassays continue to serve as rapid, easy-to-use screens delivered via ELISA formats or lateral flow assays, while molecular diagnostics provide higher sensitivity and specificity for pathogen detection in outbreak scenarios.

End users skew across diagnostic laboratories, hospitals and clinics, and research institutes, each with different procurement cycles, validation requirements, and budget horizons. Technology choices split between reader-based systems that deliver quantitation and connectivity, and reader-less formats that prioritize simplicity and low cost. Applications span cardiac monitoring, critical care, infectious disease detection, and metabolic screening, with sample types commonly including blood, feces, milk, saliva, and urine. Understanding how these segmentation axes intersect is central to product design and go-to-market prioritization because the optimal combination of analyzer capability, consumable format, and service offering varies significantly by animal type, test purpose, and care setting.

A regionally differentiated view highlighting the distinct clinical demands, regulatory nuances, and commercial pathways across major global territories

Regional dynamics shape adoption curves, regulatory pathways, and commercial priorities in ways that vendors and investors must account for when planning market entry and expansion. In the Americas, demand is concentrated around advanced companion animal care and integrated clinic workflows, supported by strong private veterinary practice networks and a willingness among owners to invest in premium diagnostics. Market participants in this region emphasize instrument performance, digital integration, and bundled consumables as differentiators, and there is growing momentum for telehealth-enabled diagnostic services.

Across Europe, the Middle East & Africa, purchasers face a diverse landscape marked by high variability in regulatory frameworks, reimbursement norms, and veterinary service infrastructure. Western European markets trend toward clinical sophistication and regulation-driven validation requirements, while certain Middle Eastern and African markets prioritize ruggedness, cost efficiency, and simplified training models. These regional contrasts require tailored product lines and flexible commercial terms to accommodate heterogeneous procurement capabilities and clinical practices.

In the Asia-Pacific region, high population densities, expanding livestock operations, and rising companion animal ownership create strong demand for scalable diagnostics. Several markets show rapid adoption of mobile-enabled diagnostics and cloud analytics, and a robust local manufacturing base in some countries has supported faster rollout of cost-competitive consumables. Overall, regional strategies must balance global technology platforms with localized product adaptations, regulatory alignment, and distribution partnerships to achieve sustainable penetration.

A strategic assessment of how incumbents, specialized veterinary firms, and innovative startups are competing and collaborating to capture value across instruments, consumables, and services

The corporate landscape in veterinary point-of-care diagnostics is characterized by a blend of established diagnostics providers, specialized veterinary focused firms, and nimble startups, each pursuing different routes to scale. Incumbent device manufacturers leverage established distribution networks and service capabilities to upsell integrated instrument-and-consumable solutions, while specialized veterinary firms emphasize clinical validation and tailored product design to meet practitioner workflows. Startups frequently focus on single high-value applications, novel assay chemistries, or digital layers that simplify interpretation and reporting.

Strategic activity centers on partnerships, licensing, and co-development agreements that accelerate time to market while spreading development risk. Common approaches include collaborations with veterinary hospital groups to pilot new diagnostics, agreements with contract manufacturers to regionalize production, and alliances with software providers to embed connectivity and analytics into clinical routines. Competitive differentiation increasingly relies on the ability to deliver end-to-end value: reliable hardware, validated consumables, responsive service, and data tools that drive clinical utility.

Firms that secure long-term service contracts, optimize reagent logistics, and provide targeted clinician education programs tend to achieve higher retention and improved lifetime revenue. Conversely, companies that underinvest in local support or fail to demonstrate clear clinical advantages face protracted adoption cycles. For stakeholders evaluating partnerships, emphasis should be placed on operational readiness, quality systems, and the ability to support multi-species validation to maximize cross-segment applicability.

Actionable strategic recommendations for vendors and investors to strengthen product portfolios, supply chains, service models, and regulatory engagement in veterinary diagnostics

Industry leaders can accelerate adoption and secure durable advantage by implementing a focused set of strategic actions. First, prioritize product architectures that offer modularity: platforms capable of supporting multiple assay types and sample matrices reduce per-unit risk and increase life cycle revenues. Investing in reader-less formats for low-cost, high-volume use while maintaining reader-based offerings for quantitative and connected workflows enables broader market coverage and pricing flexibility.

Second, strengthen supply chain resilience through regional manufacturing partnerships and multilateral sourcing agreements that reduce exposure to tariff volatility and logistical disruption. Embedding local assembly and regional reagent production can shorten lead times and improve margin stability. Third, differentiate through service models that integrate training, calibration, and digital interpretive support; subscription-based consumable plans that include automatic replenishment and remote monitoring improve customer retention and stabilize revenue forecasts.

Fourth, engage proactively with regulators and key opinion leaders to accelerate clinical validation and create clear pathways for market access. Fifth, align commercial models to end-user economics by offering tiered instruments, bundled consumables, and flexible financing to accommodate varied budget profiles across veterinary clinics, diagnostic laboratories, and research institutes. Finally, embed data capabilities to convert diagnostic outputs into actionable practice intelligence and population health insights, thereby reinforcing the value proposition for buyers and payers alike.

A transparent outline of primary and secondary research approaches, expert validation processes, and data triangulation techniques used to build actionable intelligence

The research methodology underpinning this analysis combines primary qualitative inquiry with rigorous secondary validation to ensure findings are clinically relevant and operationally grounded. Primary research included structured interviews with practicing veterinarians, laboratory directors, livestock production managers, and product development leaders, focusing on use cases, procurement decision criteria, and post-purchase support expectations. These conversations provided real-world context for product acceptance, workflow integration, and pain points associated with existing diagnostic offerings.

Secondary research drew on technical literature, regulatory guidance documents, patents, and publicly available clinical validation studies to corroborate performance claims and identify technology trajectories. Data triangulation was employed to reconcile differing perspectives across stakeholder groups and to validate trends observed in practice. Segmentation analyses were performed by cross-referencing clinical use cases with instrumentation capabilities and consumables formats to determine where product fit aligns with end-user needs.

Limitations of the methodology include variability in regulatory transparency across regions and differing levels of adoption maturity across animal types, which can affect the generalizability of some tactical conclusions. To mitigate these constraints, findings were stress-tested through scenario analysis and subjected to peer review by independent industry experts, enhancing the robustness of the recommendations presented.

A conclusive synthesis emphasizing the interplay of technology, service delivery, and operational resilience that will determine long-term success in veterinary diagnostics

In conclusion, veterinary point-of-care diagnostics are entering a phase of practical maturation where technological capability, service design, and commercial agility determine winners and losers. The convergence of portable molecular tools, improved immunoassay formats, and digital interpretation platforms provides a clear pathway for diagnostics to move from episodic use toward routine integration in both companion animal clinics and livestock operations. However, sustained adoption depends on addressing end-user economics, building resilient supply chains, and demonstrating measurable clinical utility across multi-species contexts.

Organizations that combine modular product design with strong local support, intelligent service models, and partnerships that accelerate regulatory acceptance will be best positioned to capture durable value. Tariff pressures and regional variability underscore the need for flexible manufacturing footprints and adaptive commercial terms. Ultimately, the most compelling value propositions will be those that translate rapid, accurate diagnostics into improved clinical outcomes, reduced operational waste, and enhanced population health surveillance, thereby making point-of-care testing indispensable across animal health practice.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Veterinary Point Of Care Diagnostics Market, by Animal Type

  • 8.1. Companion Animals
    • 8.1.1. Cats
    • 8.1.2. Dogs
  • 8.2. Livestock
    • 8.2.1. Cattle
    • 8.2.2. Horses
    • 8.2.3. Poultry
    • 8.2.4. Swine

9. Veterinary Point Of Care Diagnostics Market, by Test Type

  • 9.1. Biochemistry
    • 9.1.1. Chemistry Analyzer
    • 9.1.2. Electrolyte Analyzer
  • 9.2. Hematology
    • 9.2.1. Cell Counter
    • 9.2.2. Hemoglobin Analyzer
  • 9.3. Immunoassay
    • 9.3.1. Elisa
    • 9.3.2. Lateral Flow Assay
  • 9.4. Molecular Diagnostics

10. Veterinary Point Of Care Diagnostics Market, by Technology

  • 10.1. Reader Based
  • 10.2. Reader Less

11. Veterinary Point Of Care Diagnostics Market, by Sample Type

  • 11.1. Blood
  • 11.2. Feces
  • 11.3. Milk
  • 11.4. Saliva
  • 11.5. Urine

12. Veterinary Point Of Care Diagnostics Market, by Application

  • 12.1. Cardiac Monitoring
  • 12.2. Critical Care
  • 12.3. Infectious Disease
  • 12.4. Metabolic Screening

13. Veterinary Point Of Care Diagnostics Market, by End User

  • 13.1. Diagnostic Laboratories
  • 13.2. Hospitals And Clinics
  • 13.3. Research Institutes

14. Veterinary Point Of Care Diagnostics Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Veterinary Point Of Care Diagnostics Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Veterinary Point Of Care Diagnostics Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Veterinary Point Of Care Diagnostics Market

18. China Veterinary Point Of Care Diagnostics Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Agrolabo Spa
  • 19.6. B. Braun SE
  • 19.7. Biogal Galed Labs
  • 19.8. BioMerieux SA
  • 19.9. BioNote, Inc.
  • 19.10. Chembio Diagnostic Systems, Inc. by Biosynex
  • 19.11. Dispomed Ltd.
  • 19.12. Esaote SpA
  • 19.13. Fassisi GmbH
  • 19.14. FUJIFILM Holdings Corporation
  • 19.15. Heska Corporation by Mars Inc.
  • 19.16. IDEXX Laboratories, Inc.
  • 19.17. Medtronic PLC
  • 19.18. Mindray Medical International Limited
  • 19.19. Neogen Corporation
  • 19.20. Nova Biomedical Corporation
  • 19.21. Precision Biosensor Inc.
  • 19.22. Randox Laboratories Ltd.
  • 19.23. Shenzhen Mindray Animal Medical Technology Co., Ltd.
  • 19.24. Thermo Fisher Scientific Inc.
  • 19.25. Vimian Group AB
  • 19.26. Virbac Corporation
  • 19.27. Woodley Equipment Company Inc.
  • 19.28. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CATS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CATS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CATS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY DOGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY DOGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY DOGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CATTLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CATTLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CATTLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HORSES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HORSES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HORSES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY POULTRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY POULTRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY POULTRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SWINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SWINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SWINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CHEMISTRY ANALYZER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CHEMISTRY ANALYZER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CHEMISTRY ANALYZER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ELECTROLYTE ANALYZER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ELECTROLYTE ANALYZER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ELECTROLYTE ANALYZER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CELL COUNTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CELL COUNTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CELL COUNTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMOGLOBIN ANALYZER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMOGLOBIN ANALYZER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMOGLOBIN ANALYZER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ELISA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ELISA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ELISA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY READER BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY READER BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY READER BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY READER LESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY READER LESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY READER LESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BLOOD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BLOOD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY FECES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY FECES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY FECES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY MILK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY MILK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY MILK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SALIVA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SALIVA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SALIVA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY URINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY URINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY URINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CARDIAC MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CARDIAC MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CARDIAC MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CRITICAL CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CRITICAL CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CRITICAL CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY METABOLIC SCREENING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY METABOLIC SCREENING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY METABOLIC SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 178. MIDDLE EAST VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. MIDDLE EAST VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 181. MIDDLE EAST VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. AFRICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 188. AFRICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 189. AFRICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 190. AFRICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 191. AFRICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. AFRICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 193. AFRICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 200. ASIA-PACIFIC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 203. ASIA-PACIFIC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. ASIA-PACIFIC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 205. ASIA-PACIFIC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 206. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. ASEAN VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. ASEAN VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 210. ASEAN VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 211. ASEAN VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. ASEAN VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 213. ASEAN VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 214. ASEAN VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 215. ASEAN VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 216. ASEAN VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. ASEAN VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 218. ASEAN VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. GCC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 220. GCC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. GCC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 222. GCC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 223. GCC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. GCC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 225. GCC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 226. GCC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 227. GCC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 228. GCC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. GCC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 230. GCC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPEAN UNION VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPEAN UNION VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPEAN UNION VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPEAN UNION VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPEAN UNION VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPEAN UNION VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPEAN UNION VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPEAN UNION VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPEAN UNION VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPEAN UNION VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPEAN UNION VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPEAN UNION VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 243. BRICS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 244. BRICS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. BRICS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 246. BRICS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 247. BRICS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 248. BRICS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 249. BRICS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 250. BRICS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 251. BRICS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 252. BRICS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 253. BRICS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 254. BRICS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 255. G7 VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 256. G7 VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. G7 VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 258. G7 VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 259. G7 VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. G7 VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 261. G7 VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 262. G7 VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 263. G7 VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 264. G7 VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 265. G7 VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 266. G7 VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 267. NATO VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 268. NATO VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 269. NATO VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 270. NATO VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 271. NATO VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 272. NATO VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 273. NATO VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 274. NATO VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 275. NATO VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 276. NATO VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 277. NATO VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 278. NATO VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 279. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 280. UNITED STATES VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 281. UNITED STATES VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 282. UNITED STATES VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 283. UNITED STATES VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 284. UNITED STATES VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 285. UNITED STATES VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 286. UNITED STATES VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 287. UNITED STATES VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 288. UNITED STATES VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 289. UNITED STATES VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 290. UNITED